Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

The Transformative Potential of Artificial Intelligence in Life Sciences

841 views

Published on

Discover the transformative potential Artificial Intelligence has for impacting human life and the world around us. Visit https://accntu.re/2r6T2g2 to learn more.

Published in: Technology
  • Be the first to comment

The Transformative Potential of Artificial Intelligence in Life Sciences

  1. 1. ARTIFICIAL INTELLIGENCE The transformative potential for impacting human life and the world around us LOIC GIRAUD NOVARTIS ARNAB CHAKRABORTY ACCENTURE DIGITAL
  2. 2. ARTIFICIAL INTELLIGENCE IS MOVING FROM EXPERIMENTAL TO EXPONENTIAL Funding for AI startups. Annual compound growth in G20 since 2010 60% Number of AI patents. Annual compound growth in G20 since 2010 26% Source: Accenture Research, Accenture TechVision 2017 Survey, subscribed databases BIG DATA Proportion of 5400 IT and business execs investing in AI in next 3 years. 85% COMPUTING POWER AI TECHNOLOGIES
  3. 3. AI TECHNOLOGIES & APPLICATIONS HOW DOES IT ALL FIT TOGETHER? Knowledge Representation Search and Optimization Predictive Systems Biometrics, Facial & Gesture Recognition Genomic and *iomic Analysis Virtual Agent Personality Insight Expert Systems (Inference) Intelligent Automation Recommendation Systems Text, speech image & video analytics Augmented Reality Deep Learning Shallow Learning Deep Neural Networks Intelligent Products NaturalLanguage Understanding Computer Vision Speech to Text Regression SVM Audio & Signal Processing APPLICATIONS Enable intelligent Enterprise using Machine Learning & Supporting Technologies AI CAPABILITIES Complement Machine Learning to Comprehend, Reason, Predict & Optimize Constraints MACHINE LEARNING Algorithms & Architectures that allow ‘learning’ DEEP & SHALLOW LEARNING Supervised, Semi Supervised, Unsupervised, Reinforcement
  4. 4. EMPOWERING HEALTHCARE WITH ARTIFICIAL INTELLIGENCEDATACOMPLEXITY Structured, Stable, Low-Volume Unstructured, Volatile, High-Volume WORK COMPLEXITYRoutine, Predictable, Rules- based Ad-Hoc, Unpredictable, Judgment-based EFFECTIVENESS • Patient Flow Management • Clinical Workflow Management • Nursing Handoffs • Operating Room Scheduling INNOVATION • Biomedical Research • Medical Ethics Rulings • e-Consulting EFFICIENCY • Physician authorization requests • Ordering Labs • e-Prescribing • Appointment Scheduling EXPERT • Robotics-aided surgery • Medical specialist diagnosis • Prescription advising • Simple medical diagnosis AUGMENT AUTOMATE
  5. 5. IN THE PRESS QUANTUM COMPUTING Quantum computing to help speed up drug discovery VISUAL ASSISTANT AI-powered solution, to assist visually impaired people in gaining more insight INTELLIGENT PATIENT CARE ADVANTICS™ platform to improve patient outcomes and reduce cost of treating cardiovascular conditions TUMOR BOARD Digital Healthcare for cancer patients based on Roche’s NAVIFY Tumor Board solution.
  6. 6. AI-EMPOWERED BUSINESSES KNOW THE POWER OF • DATA • AUTOMATION & AUGMENTATION • FOCUS & EXPERIMENTATION • THE NETWORK EFFECT • RESPONSIBLE AI COMPREHEND LEARN SENSE ACT DECIDE
  7. 7. DRUG DISCOVERY Apply ML to scientific data to predict activity and toxicity with much higher precision PRECISION MEDICINE Identify patterns for multifactorial diseases and target those with high specificity CLINICALTRIALS Predict drug interaction with targets, allowing clinical trial experimentation to be reduced PHARMACOVIGILANCE Learn from safety pattern to predict risks of adverse effects DISEASE MANAGEMENT AI enhances patient monitoring to better manage diseases THE NEW POSSIBLE IN LIFE SCIENCES
  8. 8. EMPOWERING NEW BUSINESS OUTCOMES AT SPEED AND SCALE NEW SPEED TO MARKET REDEFINE WORKFORCE CREATE NEW REVENUE STREAM OPEN NEW MARKETS REIMAGINE PRODUCTS & SERVICES
  9. 9. HOW NOVARTIS USES AI AS COMPETITIVE ADVANTAGE
  10. 10. NOVARTIS LEADERS BELIEVE DIGITAL WILL TRANSFORM HEALTHCARE Le Temps, Oct 2017 J. Reinhart, Novartis chairmanFinancial Times, Sep 2017, Vas Narasimhan, Novartis CEO World Economic Forum Davos, Jan 2018 AI WILL HELP NOVARTIS SAVING BILLIONS IN NEW DRUG DEVELOPMENT
  11. 11. NOVARTIS 5 YEARS DIGITAL AMBITION ADVANCED ANALYTICS COGNITIVE & RPA ENTERPRISE DATA REPOSITORY IOT API CLOUD BUSINESS STRATEGY INNOVATE SELL OPERATE ENTERPRISE-WIDE ENABLERS TECHNOLOGY CAPABILITIES INDUSTRY LEADER IN ADVANCED ANALYTICS 1. Data as a strategic asset 2. World-class advanced analytics capabilities NEW NOVARTIS DIGITAL OPERATING MODEL 3. Empowered leader and business ownership 4. Expert support and supporting governance and incentives DIGITAL TALENT AND CAPABILITY PROGRAM 5. Leadership capabilities, new way of working and attractive careers for digital talent
  12. 12. AROUND THE PATIENT INNOVATOR DIGITAL MEDICINES COMPANIES FOCUSED ONTHE PATIENT JOURNEY • Drive HCP engagement through improved multichannel targeting • Patient journey analysis using RWE to improve drug adherence CREATE DIFFERENTIATED SERVICES AND RUN EFFICIENT OPERATIONS LEAN INNOVATORS FINANCIALLY-DRIVEN, EFFICIENT OPERATORS • Improve clinical trial selection by differentiating responders to non- responders • Ensure 100% up-time of manufacturing machines to ensure drug fulfillment • Automated financial forecasting NEW HEALTH DIGITALS DIGITAL-TO-HEALTH OR HEALTH-TO-DIGITAL COMPANIES • Remote clinical trial monitoring • Illness detection through image recognition
  13. 13. It takes years and billions to discover and commercialize new drugs – though application of AI, Novartis aims to reduce costs of drug development by 25% AI FOR DRUG DEVELOPMENT AI OPTIMIZES CLINICAL TRIALS 1. Improve global trial cost- efficiency 2. Optimized site allocation 3. Give earlier notification of trials falling behind schedule 4. Identify non-enrolling sites 5. Provide an evidence- based and forward- looking quality risk assessment
  14. 14. Novartis visits 100000 Health Care Professionals every day – But do we address the right HCPs and do we address them in the right way? AI FOR INCREASING TOP LINE SALES AI OPTIMIZES HCP ENGAGEMENTS 1. Increase Drug prescriptions 2. Timely and targeted actions with HCP 3. Optimize resource allocation 4. Better ROI on marketing spend
  15. 15. AI REQUIRES NEW SKILLS Novartis hires new talent, trains existing workforce and leverages its partner ecosystem – deploying a federated hub and spoke model HIRING Selective recruitments for data scientists and data engineers DIGITAL ACADEMY Train executives and analytics workforce to understand the art of possible PARTNER ECOSYSTEM Complement workforce and infuse innovation using differentiated sourcing and engagement models ROLES DATA SCIENTIST SOLUTION ARCHITECT BUSINESS ANALYST BIG DATA ENGINEER DATA ANALYST VISUALIZATION EXPERT PROJECT MANAGER PRIVACY EXPERT BUSINESS DOMAIN EXPERT(S)
  16. 16. THE NEW IMPERATIVES GETTING YOUR AI TRANSFORMATION RIGHT NEW COLLABORATION MODELS GOVERNANCE ECOSYSTEM OF INNOVATION E2E CAPABILITIES THAT SCALE OPERATING MODEL CHANGE MANAGEMENT
  17. 17. UNTRAP NEW DATA & INTELLIGENCE New data sources and new data science for speed to insight DISCOVER NEW BUSINESS OPPORTUNITIES New business models and revenue streams for speed to confidence DEFINE NEW WAYS OF WORKING Responsible AI implementation for speed to adoption SCALE WITH NEW AGILITY Automation and augmentation via Platforms, Ecosystems & Solutions for speed to efficiency DO THINGS DIFFERENTLY DO DIFFERENT THINGS CREATE NEW PRODUCTS & SERVICES New ways to engage customers for speed to value HOW WE DO IT HUMAN + MACHINE = SUPERPOWERS
  18. 18. LEARN MORE: ACCENTURE ARTIFICIAL INTELLIGENCE www.accenture.com/AIQ

×